arteries and 19 superior mesenteric arteries) targeted with 44 fenestrations and 17 scallops; 44 target vessels were stented with 41 covered stents and 3 bare-metal stents. Median follow-up was 255 days (range, 34-1352 days). Of the 22 completion endoleaks, 12 were type III, one was type IA, and 9 were indeterminate (either type IA or type III; Table) . No type I or type III endoleaks were identified on initial postoperative computed tomography angiography. Furthermore, no type I or type III endoleaks were identified on any follow-up imaging. Of 12 patients with at least 6-month follow-up, 6 had sac regression, 5 had stable sac diameter, and 1 had sac expansion. The patient with sac expansion underwent reintervention for persistent type II endoleak. There were no aneurysm ruptures or deaths.
IP071.

Comparison of Fenestrated Endovascular and
Objective: The aim of this monocentric retrospective study was to compare outcomes of fenestrated endovascular aneurysm repair (FEVAR) and open surgical repair (OR) of suprarenal abdominal aortic aneurysms and type IV thoracoabdominal aneurysms (TAAAs).
Methods: Consecutive patients undergoing elective FEVAR and OR of suprarenal and type IV TAAAs between January 2012 and November 2015 were included. Choice between FEVAR and OR was based on anatomic criteria and the patient's comorbidities. In the OR group, an extracorporeal circulation was systematically used to provide oxygenated isothermic blood to the renal and the visceral arteries during aortic clamping.
Results: During the study period, 26 patients underwent FEVAR and 26 underwent OR. Patients in the FEVAR group were significantly older (FEVAR, 74 6 8 years; OR, 67 6 8 years; P < .001) and had a lower preoperative glomerular filtration rate (FEVAR, (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) (FEVAR and OR groups, 2/26 [7.7%] ). Moderate to severe complication rates were 54% (14/26) in the FEVAR group and 65% (17/26; P ¼ .4) in the OR group. Permanent paraplegia occurred in one (4%) FEVAR patient and two (8%) OR patients. In the FEVAR group, two (8%) patients required permanent dialysis. In the OR group, four (15%) patients required transient dialysis. The mean followup time was 37 6 20 months after FEVAR and 35 6 18 months after OR. At 24 months, the actuarial survival rate was significantly higher in the OR group (FEVAR group, 62%; OR group, 92%; log-rank test, P ¼ .03), and estimated freedom from reintervention rates (FEVAR vs OR group, 64% vs 64%; log-rank test, P ¼ .63) were not significantly different between both groups.
Conclusions: In this study, no significant difference in terms of postoperative mortality, complication, and reintervention rates could be identified between FEVAR and OR for suprarenal and type IV TAAAs. OR provided good midterm results.
Author Disclosures: E. Allaire: Nothing to disclose; I. Ben Abdallah: Nothing to disclose; F. Cochennec: Nothing to disclose; P. Desgranges: Nothing to disclose; J. Sénémaud: Nothing to disclose; J. Touma: Nothing to disclose. Objective: Readmissions after acute type A aortic dissection (AAAD) are not well described. Characterization of causes and identification of predictors of readmission could result in improved outcomes. We evaluated our experience to determine the rate and to identify risk factors for readmission after open AAAD repair managed at our institution during a decade.
IP073.
Predictors and Descriptors of Readmissions After Acute Aortic Dissection
Methods: Of the 435 patients who presented to our service between 2004 and 2014, there were 411 who underwent repair for AAAD. Of these, 357 survived the initial hospitalization and were evaluated for this analysis. Follow-up was performed through prospective phone contact and retrospective review of records under an Institutional Review Boardapproved protocol to obtain the cause, frequency, length of stay, management, and related characteristics for each reported readmission and emergency department visit. Data were analyzed by univariate and multivariable analysis.
Results: Of those who survived AAAD repair, 64 (16%) had readmissions within 30 days. The median interval between initial discharge and readmission was 7 (interquartile range, 3-21) days. The 30-day readmission rate was slightly more in women (23% vs 16%), younger patients (53 vs 57 years), and substance abusers (17% vs 7%; P < .008). The median readmission length of stay was 3 days (interquartile range, 1-12 days). Multivariable analysis identified age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection to be predictive of 30-day readmissions. During a median follow-up of 5 years, 204 (57%) patients were readmitted for various aortic (17%), cardiac (15%), neurologic (10%), hypertensive crisis (10%), and gastrointestinal (15%) reasons. Recurrent or persistent pain (21%) was one of the most significant predictors for multiple readmissions (P < .001) in addition to connective tissue disorder (odds ratio, 3.2; P < .016). Overall, 12% of patients required aortic reinterventions during a median of 2 years after initial AAAD repair. Of these, proximal aortic repair (redo or root) was performed in 22% of cases and distal thoracoabdominal aortic repair in 88% (36). Independent correlates of aortic event readmissions included age >70 years, connective tissue disorder, female sex, postoperative bleeding complications, low baseline glomerular filtration rate, and multiple readmissions. Long-term readmission-free and aortic event-free survival at 1 year and 5 years were 40% and 56% and 87% and 76%, respectively.
Conclusions: Readmission after repair of AAAD is common. Age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection were strong predictors of early readmissions. Recurrent (chest, back, abdominal) pain was significantly correlated with multiple readmissions and low event-free survival. Routine surveillance after repair of AAAD is recommended with closer attention to patients with recurrent or persistent pain.
Author Disclosures: K. M. Charlton-Ouw: Nothing to disclose; A. L. Estrera: Nothing to disclose; I. Jamshidy: Nothing to disclose; C. C. Miller: Nothing to disclose; A. Ray: Nothing to disclose; H. J. Safi: Nothing to disclose; H. K. Sandhu: Nothing to disclose; A. Tanaka: Nothing to disclose.
IP075.
Prevalence of Myocardial Injury After Noncardiac Surgery in Endovascular Aneurysm Repair Patients: Single-Center Analysis Using Contemporary and High-Sensitivity Troponin I Measurements* Objective: Myocardial injury after noncardiac surgery (MINS) refers to prognostically relevant myocardial injury due to ischemia that occurs during or within 30 days after noncardiac surgery (NCS). Its prognostic impact has recently been established, so that MINS has been independently associated with 30-day mortality after NCS, and any detectable cardiac troponin T (cTnT; 0.01 ng/mL) is associated with increased longterm mortality after vascular surgery. The characteristics and prognostic importance of MINS in vascular surgery patients are poorly described, and the prevalence of MINS in endovascular aneurysm repair (EVAR) patients is unknown. Also, most studies use fourth-generation cTnT, which can have significant baseline increases in chronic kidney disease patients. Unlike cTnT, cardiac troponin I (cTnI) is more specific for myocardial injury in chronic kidney disease patients. This work aimed to evaluate the prevalence of MINS in EVAR patients and its impact on all-cause mortality using contemporary cTnI and high-sensitivity troponin I (hSTnI) measurements.
Methods: Patients with asymptomatic abdominal aortic aneurysm treated by standard EVAR between 2008 and 2017 and with at least one measurement of cTnI or hSTnI (Abbott, Abbott Park, Ill) in the first 48 hours after surgery were retrospectively analyzed. MINS was defined as the value exceeding the 99th percentile of a normal reference population with a coefficient of variation<10%, which, for the study population, was >0.032 ng/mL for cTnI and 0.0114 ng/mL (female) and 0.027 ng/mL (male) for hSTnI. Patients' demographics, medication, access, anesthesia, blood loss, and incidence of postimplantation syndrome were also evaluated.
Results: There were 136 consecutive patients included (95.6% male; mean age, 75.51 years). Mean follow-up was 37.21 months. The mortality rate was 31.6% (n ¼ 43), with two fatalities at 30 days. The incidence of MINS was 16.2% (n ¼ 22). In 86.4% of the cases, it was completely asymptomatic. Congestive heart failure was significantly associated with higher prevalence of MINS (P ¼ .0045), but no association was found with the remaining comorbidities. Anesthesia, hemoglobin loss, and postimplantation syndrome were also not associated with this end point (P > .05). Patients preoperatively medicated with aspirin with or without statin were found to have higher prevalence of MINS (P ¼ .009 and P ¼ .016, respectively). Survival analysis revealed that MINS was significantly associated with long-term all-cause mortality (P ¼ .005). Because congestive heart failure can cause baseline troponin elevations, a subgroup analysis was performed excluding these patients. Prevalence of MINS in this subgroup was 13.6%, and association with long-term all-cause mortality was still present (P ¼ .001).
Conclusions: Prevalence of MINS in EVAR patients is higher than that reported for nonspecific NCS. MINS was found to be associated with long-term all-cause mortality in EVAR patients. The majority of patients were asymptomatic and would have gone undetected without postoperative troponin measurements.
Author Disclosures: A. Mansilha: Nothing to disclose; J. Neves: Nothing to disclose; J. Sousa: Nothing to disclose.
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Two-Device Closure Method for LargeDiameter Arteriotomies in Percutaneous Endovascular Aortic Repair
Cullen K. McCarthy, Feroz Maqbool, Joshua L. Gierman. University of Oklahoma, Oklahoma City, Okla
Objective: Percutaneous endovascular aortic repairs are associated with access site complications. As endovascular devices become more sophisticated and frequently require large-bore arteriotomies, several devices and techniques have been described to aid in the percutaneous closure of arteriotomies, including collagen plug devices (Angio-Seal; Terumo Interventional Systems, Somerset, NJ) and percutaneous suturemediated closure devices (Perclose; Abbott Vascular, Santa Clara, Calif). Two-device preclose technique using two Perclose devices has been well established. Combined Perclose and Angio-Seal technique has been described for arteriotomies up to 14F because of instances of only a single Perclose device successfully predeployed during the preclose technique. We sought to determine whether a hybrid Perclose and Angio-Seal closure technique would safely and effectively establish hemostasis in large-bore arteriotomies up to 20F.
Methods: Before sheath insertion, one Perclose device was predeployed. At the end of percutaneous endovascular aortic repair, device sheath and introducer were withdrawn over a 0.035-inch wire, and partially deployed Perclose was fully deployed. The sheath and introducer were fully withdrawn, and the arteriotomy was closed with a 6F Angio-Seal vascular closure device. Patients were observed at day 1 and day 30 and at least 1 year after intervention.
Results: A composite end point of complications was defined as an access site-related bleed or hematoma or retroperitoneal hematoma that required blood transfusion, pseudoaneurysm, arteriovenous fistula, or dissection. The combined technique was initially successful in 44 of 46 arteriotomies (95.6%) in 24 of 26 patients (92.3%) with no conversions to cutdown. Sheath sizes ranged from 10F to 20F outer diameter (OD), with an average of 15.85F OD. In the two instances in which satisfactory hemostasis using this method was not initially achieved, Perclose failure and Angio-Seal failure each accounted for a singled episode and required manual compression. Both instances occurred in a 20F arteriotomy. The only late complication of this method was a subcentimeter pseudoaneurysm in the arteriotomy where the perclose device did not deploy. There were no other early or late complications in this series.
Conclusions: Large-bore arteriotomies can be safely and effectively closed using a hybrid percutaneous closure technique for sheaths up to 19F OD. Further investigation is needed to assess the value of this closure in 20F OD sheaths and above. 
